Metsera is a clinical-stage biopharmaceutical company developing next-generation treatments for obesity and metabolic diseases using their innovative platforms and Nutrient-Stimulated Hormone analog peptides.

Evommune, Inc. is a biotechnology company focused on developing treatments for chronic inflammatory diseases.